Nebulizers Market: Technological Advancements in Respiratory Equipment to Drive Global Market

Nebulizers are devices used for spraying liquid evenly in medicinal drugs for inhaling or other purposes. A nebulizer is a device that changes liquid medicine into a mist that is then inhaled via a mask or a mouthpiece. As asthma medication is sometimes prescribed via nebulizer, it holds a significant share on account of the increasing rate of patients suffering from asthma. Respiratory problems that results from smoking habits, changing lifestyle, and long term exposure to environmental pollution are projected to serve as the key factors augmenting the sales growth of the global nebulizers market in the near future.

Owing to the rising prevalence of respiratory disorders such as COPD, asthma, and cystic fibrosis, there is a growing demand for nebulizers all over the world. Technological innovations in medical devices, hugely profitable presence of both regional and international players are likely to serve as the emerging trends of the nebulizers market. Additionally, the rise in geriatric patients globally is also contributing to future market growth.

The advent of advanced manufacturing processes is creating revenue generation opportunities for the nebulizers market as well as for other medical device manufacturers. In the coming years, major advancements in respiratory medical devices are predicted to boost the global nebulizer market. To meet the demands of the healthcare sector, some players of the global nebulizers market are expanding their product portfolio and offer better quality products in the coming years. For instance, The production of an advanced hydrogen-oxygen AMS-H-03 nebulizer was announced in April 2020 by Asclepius Meditech Co. Ltd. This nebulizer will help in the treatment of COVID19 patients reduce the shortage of ventilators in China.

Get Sample Copy of the Report @

The nature of the nebulizers market is highly fragmented on account of the presence of multiple players. Companies are investing in improving product portfolio and brand expansion to gain significant position in the overall market competition. Other players are making heavy investments on research and development for the manufacturing of advanced products. Some of the key players of the global nebulizers market include Philips Healthcare, PARI Respiratory Equipment Inc., Omron Healthcare Inc., GF Health Products Inc., GE Healthcare Ltd., Covidien Plc., CareFusion Corporation, Allied Healthcare Products Inc., and others.

High Prevalence of Respiratory Diseases will Augment Growth of Market

North America had the highest number of asthma and COPD cases in the world in 2012, as per the Centers for Disease Control and Prevention (CDC). Asthma, cystic fibrosis, and COPD are becoming increasingly common around the world. Their prevalence will help increase the sales projections of the nebulizers market in the long run.  The exact cause of asthma and cystic fibrosis is unknown; however, risk factors include hereditary conditions (inherited from parents) and environmental pollution (chemical irritant or UV ray). COPD, on the other hand, is primarily caused by cigarette smoking. This implies that the rise in number of smoker’s population will also have an indirect but positive influence on the overall growth of this market.

Make an Enquiry Before Buying @

Geographically, The Asia Pacific nebulizers market is expected to grow rapidly due to factors such as the incidences of respiratory disorders such as asthma and bronchitis, rising demand for targeted therapies, growing healthcare awareness, and rising disposable income.  Furthermore, healthcare and economic development reforms would increase government funding for intensive R&D, thereby, helping this region emerge as the fastest growing market for nebulizers in the coming years. On the other side, the market in North America will witness significant growth prospects in the next couple of years. This is accountable to an increase in the incidence of various respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. Other factors driving market growth in the region include technological advancements in healthcare and increased adoption